Clarke Robert, Emberson Jonathan R, Parish Sarah, Palmer Alison, Shipley Martin, Linksted Pamela, Sherliker Paul, Clark Sarah, Armitage Jane, Fletcher Astrid, Collins Rory
Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, England.
Arch Intern Med. 2007 Jul 9;167(13):1373-8. doi: 10.1001/archinte.167.13.1373.
The relevance of blood lipid levels as risk factors for ischemic heart disease (IHD) in older people is uncertain; hence, cholesterol-lowering therapy is not routinely prescribed in older populations.
We assessed IHD mortality associations with plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, apolipoprotein B, and apolipoprotein A(1) measured in older men. Ischemic heart disease was assessed in a 7-year follow-up of a cohort of 5344 men (mean age, 76.9 years), including 74.3% without cardiovascular disease (CVD) or statin use and 25.6% with CVD or statin use. Hazard ratios (HRs) for 447 deaths from IHD were estimated for a 2-SD difference in usual plasma lipid levels.
Ischemic heart disease mortality was not significantly associated with total cholesterol levels in all men (HR, 1.05), but a significant positive association in men without CVD and a slight nonsignificant inverse association in men with CVD were observed (HR, 1.47 vs 0.84). The patterns were similar for low-density lipoprotein cholesterol levels (HR, 1.50 vs 0.98) and for apolipoprotein B levels (HR, 1.68 vs 0.93). Ischemic heart disease risks were inversely associated with high-density lipoprotein cholesterol levels and with apolipoprotein A(1) levels in men with and without CVD. Ischemic heart disease risks were strongly associated with total/high-density [corrected] lipoprotein cholesterol levels (HR, 1.57) and apolipoprotein B/apolipoprotien [corrected] A(1) levels (HR, 1.54), and remained strongly related at all ages.
Blood lipid levels other than total cholesterol levels were associated with IHD in older men. Differences in lipid levels that are achievable by statin use were associated with about a one-third lower risk of IHD, irrespective of age.
血脂水平作为老年人缺血性心脏病(IHD)危险因素的相关性尚不确定;因此,老年人中降胆固醇治疗并非常规处方。
我们评估了IHD死亡率与老年男性血浆总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、载脂蛋白B和载脂蛋白A(1)水平之间的关联。在对5344名男性(平均年龄76.9岁)队列进行的7年随访中评估缺血性心脏病,其中74.3%无心血管疾病(CVD)或未使用他汀类药物,25.6%有CVD或使用他汀类药物。针对447例IHD死亡病例,估计了常见血脂水平每相差2个标准差时的风险比(HRs)。
在所有男性中,IHD死亡率与总胆固醇水平无显著关联(HR,1.05),但在无CVD的男性中观察到显著正相关,在有CVD的男性中观察到轻微的非显著负相关(HR,1.47对0.84)。低密度脂蛋白胆固醇水平(HR,1.50对0.98)和载脂蛋白B水平(HR,1.68对0.93)的模式相似。无论有无CVD,IHD风险均与高密度脂蛋白胆固醇水平和载脂蛋白A(1)水平呈负相关。IHD风险与总胆固醇/高密度脂蛋白[校正后]胆固醇水平(HR,1.57)和载脂蛋白B/载脂蛋白[校正后]A(1)水平(HR,1.54)密切相关,且在所有年龄段均保持密切关系。
除总胆固醇水平外,其他血脂水平与老年男性的IHD相关。使用他汀类药物可达到的血脂水平差异与IHD风险降低约三分之一相关,与年龄无关。